Back to Search Start Over

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Source :
Plus Company Updates. December 2, 2024
Publication Year :
2024

Abstract

BOSTON, Mass: Cue Biopharma, Inc has issued the following news release: Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.818777328